Wherly P. Hoffman

1.1k total citations
33 papers, 819 citations indexed

About

Wherly P. Hoffman is a scholar working on Physiology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Wherly P. Hoffman has authored 33 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Health, Toxicology and Mutagenesis and 7 papers in Cancer Research. Recurrent topics in Wherly P. Hoffman's work include Effects and risks of endocrine disrupting chemicals (7 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Statistical Methods in Clinical Trials (4 papers). Wherly P. Hoffman is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (7 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Statistical Methods in Clinical Trials (4 papers). Wherly P. Hoffman collaborates with scholars based in United States, Netherlands and Canada. Wherly P. Hoffman's co-authors include Michael L. Garriott, Daniel Ness, Levin Va, Patrick C. May, Steven M. Paul, Margaret M. Racke, Deena L. Hepburn, Bruce D. Gitter, William H. Jordan and Laura Boone and has published in prestigious journals such as Journal of Neuroscience, Journal of Pharmacology and Experimental Therapeutics and The Annals of Statistics.

In The Last Decade

Wherly P. Hoffman

33 papers receiving 769 citations

Peers

Wherly P. Hoffman
Ian N. Bird United Kingdom
Steven K. Duddy United States
Won‐Ki Kim South Korea
Dongxiao Sun United States
Zhen Ren China
William H. Hanneman United States
Hiral Patel United States
Ian N. Bird United Kingdom
Wherly P. Hoffman
Citations per year, relative to Wherly P. Hoffman Wherly P. Hoffman (= 1×) peers Ian N. Bird

Countries citing papers authored by Wherly P. Hoffman

Since Specialization
Citations

This map shows the geographic impact of Wherly P. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wherly P. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wherly P. Hoffman more than expected).

Fields of papers citing papers by Wherly P. Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wherly P. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wherly P. Hoffman. The network helps show where Wherly P. Hoffman may publish in the future.

Co-authorship network of co-authors of Wherly P. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Wherly P. Hoffman. A scholar is included among the top collaborators of Wherly P. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wherly P. Hoffman. Wherly P. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Lan, Sarah Wright, Mike Lee, et al.. (2012). Quantifying Amyloid Beta (Aβ)–Mediated Changes in Neuronal Morphology in Primary Cultures: Implications for Phenotypic Screening. SLAS DISCOVERY. 17(6). 835–842. 11 indexed citations
2.
Gullapalli, Rampurna Prasad, Elaine Merisko‐Liversidge, Erich Goldbach, et al.. (2011). A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs. Journal of Pharmaceutical Sciences. 101(4). 1462–1474. 18 indexed citations
3.
Hoffman, Wherly P., et al.. (2009). Estimating leukocyte, platelet, and erythrocyte counts in rats by blood smear examination. Veterinary Clinical Pathology. 38(2). 157–162. 9 indexed citations
4.
Bercu, Joel P., Wherly P. Hoffman, Cindy Lee, & Daniel Ness. (2008). Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance. Regulatory Toxicology and Pharmacology. 51(3). 270–277. 14 indexed citations
5.
Cooper, Dale M., et al.. (2005). Duration of clinical effects and absence of referred hyperalgesia after femoral vein cannulation in rats.. PubMed. 55(5). 440–4. 3 indexed citations
6.
Harris, David T., A.G.B. Templeton, Ross McD. Young, et al.. (2005). Respiratory function in rats restrained for extended periods: Assessment of the effects of bethanecol. Journal of Pharmacological and Toxicological Methods. 52(1). 83–89. 11 indexed citations
7.
8.
Cooper, Dale M., et al.. (2005). Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic.. PubMed. 55(4). 344–53. 22 indexed citations
9.
Hoffman, Wherly P., et al.. (2004). Relative cytotoxicity values at the lowest effective concentration for 12 positive chemicals in the in vitro micronucleus test utilizing Chinese hamster ovary cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 561(1-2). 153–158. 8 indexed citations
10.
Garriott, Michael L., et al.. (2002). A protocol for the in vitro micronucleus test. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 517(1-2). 123–134. 65 indexed citations
11.
Garriott, Michael L., et al.. (2002). A protocol for the in vitro micronucleus test. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 521(1-2). 103–112. 72 indexed citations
12.
Burkhard, Mary Jo, et al.. (2001). Evaluation of the Erythroid Regenerative Response in Two Different Models of Experimentally Induced Iron Deficiency Anemia. Veterinary Clinical Pathology. 30(2). 76–85. 19 indexed citations
13.
Vandenhende, François, et al.. (1999). Construction of an Optimal Destructive Sampling Design for Noncompartmental AUC Estimation. Journal of Pharmacokinetics and Biopharmaceutics. 27(2). 191–212. 6 indexed citations
14.
Thomas, Craig E., et al.. (1999). Inhibition of Iron-Dependent and Ischemia-Induced Brain Damage by the α-Tocopherol Analogue MDL 74,722. Experimental Neurology. 155(1). 103–108. 12 indexed citations
15.
Hoffman, Wherly P., et al.. (1999). Effects of Inhalation Exposures to an M1-Receptor Agonist on Ventilation in Rhesus Monkeys. Drug and Chemical Toxicology. 22(4). 595–611. 1 indexed citations
16.
Hoffman, Wherly P., et al.. (1996). Validation of an automated image analysis micronucleus scoring system. Mutation Research/Genetic Toxicology. 370(1). 65–73. 11 indexed citations
17.
Oberly, T.J., Wherly P. Hoffman, & Michael L. Garriott. (1996). An evaluation of the twofold rule for assessing a positive response in the L5178Y TK+/− mouse lymphoma assay. Mutation Research/Genetic Toxicology. 369(3-4). 221–232. 8 indexed citations
18.
Allen, David L., et al.. (1996). The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 341–349. 11 indexed citations
19.
Hoffman, Wherly P., et al.. (1994). Utilization of a short-term male reproductive toxicity study design to examine effects of α-chlorohydrin (3-chloro-1,2-propanediol). Reproductive Toxicology. 8(3). 237–250. 14 indexed citations
20.
Durako, Michael J., Russell H. Goddard, Wherly P. Hoffman, & Jean M. Lawrence. (1979). Malate and lactate dehydrogenase activities in the pyloric caeca of Luidia clathrata (Echinodermata: Asteroidea). Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 62(2). 127–128. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026